Is the Dietary miR-193b a Novel Cell Cycle Arresting Source for Breast Carcinoma? †
Abstract
:Acknowledgment
Conflicts of Interest
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Gurbuz, N.; Celik, D.A. Is the Dietary miR-193b a Novel Cell Cycle Arresting Source for Breast Carcinoma? Proceedings 2017, 1, 1014. https://doi.org/10.3390/proceedings1101014
Gurbuz N, Celik DA. Is the Dietary miR-193b a Novel Cell Cycle Arresting Source for Breast Carcinoma? Proceedings. 2017; 1(10):1014. https://doi.org/10.3390/proceedings1101014
Chicago/Turabian StyleGurbuz, Nilgun, and Dilek Asci Celik. 2017. "Is the Dietary miR-193b a Novel Cell Cycle Arresting Source for Breast Carcinoma?" Proceedings 1, no. 10: 1014. https://doi.org/10.3390/proceedings1101014
APA StyleGurbuz, N., & Celik, D. A. (2017). Is the Dietary miR-193b a Novel Cell Cycle Arresting Source for Breast Carcinoma? Proceedings, 1(10), 1014. https://doi.org/10.3390/proceedings1101014